Subcutaneous-Insulin-Resistance Syndrome

Thomas C. Chalmers, Werner O. Richter, Peter Schwandt, Neil H. White, Julio V. Santiago, P. Dandona, V. Fonseca, A. G. Beckett, David S. Schade, William C. Duckworth

Research output: Contribution to journalLetterpeer-review

1 Scopus citations


To the Editor: It is probable that every aging investigator has had the same experience, but it is frustrating to find that a current article in the Journal (July 17 issue)1 fails to mention important original work on the same topic. Twenty-seven years ago, Moore, Mitchell, and I2 studied the absorption of subcutaneously and intramuscularly injected 131I-labeled insulin, by direct measurement over the injection site. At the time, apparently no one else had studied this topic in such a direct way. Although the paper was written before we began to appreciate the implications of the Type II (beta) error, we.

Original languageEnglish
Pages (from-to)49-51
Number of pages3
JournalNew England Journal of Medicine
Issue number1
StatePublished - Jan 1 1987


Dive into the research topics of 'Subcutaneous-Insulin-Resistance Syndrome'. Together they form a unique fingerprint.

Cite this